Metabotropic glutamate receptor antagonists and their use for treating central nervous system diseases

Details for Australian Patent Application No. 2005200633 (hide)

Owner NPS Pharmaceuticals, Inc.

Inventors Stormann, Thomas M; Delmar, Eric G; Barmore, Robert; Walton, Ruth; Travato, Richard; Shcherbakova, Irina; Sheehan, Susan M; Smith, Daryl L; Moe, Scott T; Van Wagenen, Bradford C.

Agent FB Rice

Pub. Number AU-A-2005200633

Parent 778063

Filing date 11 February 2005

Wipo publication date 17 March 2005

International Classifications

C07D 241/44 Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings

A61P 025/00 Drugs for disorders of the nervous system

A61K 031/404

A61K 031/495 - having six-membered rings with two nitrogen atoms as the only ring hetero atoms, e.g. piperazine

C07D 333/68 Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom

C07D 333/38 Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom

C07D 307/84 Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom

C07D 307/68 Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom

C07D 213/82 Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members

C07D 209/42 Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom

C07D 215/54 Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems

Event Publications

3 March 2005 Complete Application Filed

17 March 2005 Application Open to Public Inspection

  Published as AU-A-2005200633

7 December 2006 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005200634-Tumor necrosis factor receptor-derived peptide analogues

2005200632-Difference detection methods using matched multiple dyes